Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCP tacrolimus versus immediate-release tacrolimus in lung transplant recipients
NL-OMON53377Phase 3Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2020
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tacrolimus in lung transplantation (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Absolute change in eGFR after 2 years. Started Jul 2020; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
lung transplantation
Beyond the preview
Go deeper on NL-OMON53377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53377.